Lille, France

Rémy Hanf

This inventor holds 23 USPTO granted patents and 9 published patent applications and 7 EPO patents, primarily in Liver Disease Treatment. Top assignee: Genfit. Active years: 2012-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rémy Hanf. Retrieved from https://idiyas.com/inventor/remy-hanf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 23 

% Patents Active = 95.7

 

Average Co-Inventor Count = 1.6

ph-index = 7

Forward Citations = 111(Granted Patents)


Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Cholestatic Diseases
Liver Disorders
Non-Alcoholic Fatty Liver
Non-Alcoholic Steatohepatitis
Liver Fibrosis
1,3-Diphenylprop-2-en-1-one
Fibrosis Treatment
Cancer Treatment
Substituted Derivatives
Diagnostic Methods
23 patents (USPTO):Explore Patents

Title: Innovations by Rémy Hanf in Medical Treatments

Introduction

Rémy Hanf, an esteemed inventor based in Lille, France, has made significant contributions to the field of medical treatments through his innovative research and patenting efforts. With a total of 12 patents to his name, Hanf's work primarily focuses on the development of compounds aimed at treating various diseases, including cholestatic diseases and cancers.

Latest Patents

Among Hanf's latest patents is a groundbreaking approach for the treatment of cholestatic diseases. His invention involves the use of the compound 1-[4-methylthiophenyl]-3-[3,5-dimethyl-4-carboxydimethyl-methyloxyphenyl]prop-2-en-1-one, known commercially as Elafibranor or GFT505. This compound is specifically designed for the treatment of Primary Biliary Cholangitis (PBC) and Primary Sclerosing Cholangitis (PSC). Additionally, Hanf has developed methods for treating fibrosis and cancers with the same compound, showcasing its versatility and potential in addressing critical health issues.

Career Highlights

Rémy Hanf is affiliated with Genfit, a biopharmaceutical company that is at the forefront of developing innovative therapies for liver diseases. His work at Genfit exemplifies his commitment to advancing medical science and improving patient outcomes through targeted therapies.

Collaborations

Collaborating with prominent colleagues such as Dean Hum and Raphael Darteil, Hanf has contributed to research efforts that push the boundaries of traditional treatment methods. These collaborations reflect not only the collective expertise of his team but also the interdisciplinary approach that is crucial for driving innovations in healthcare.

Conclusion

Rémy Hanf stands out as a notable inventor whose work has the potential to transform treatments for cholestatic diseases, fibrosis, and cancers. His relentless pursuit of innovation, coupled with effective collaborations, underscores the vital role inventors play in advancing medical science and improving lives. As he continues to develop new therapies, the impact of his inventions is likely to be felt across the healthcare landscape in the years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…